Introduction {#S1}
============

In animal organisms, haploid or near-haploid somatic cells arise from pathological processes such as parthenogenesis or aberrant chromosome loss in tumorigenesis ([@B28]). The haploid state is unstable in mammalian somatic cells, and spontaneous whole-genome duplication converts haploid cells or embryos into diploid in several days or a few weeks ([@B16]; [@B1]; [@B30]). This is in sharp contrast to plant or fungus cells, which in general proliferate stably in the haploid state. Though mammalian haploid cells are promising tools for mammalian genomics and engineering, their unstable nature limits the utility of haploid cell technology ([@B12]). The cause of haploid instability in mammalian somatic cells remains largely elusive. Several recent studies have found that haploid mammalian somatic cells commonly suffer severe mitotic delay and/or cell division failure, which potentially makes an important contribution to the progression of diploidization ([@B11]; [@B14]; [@B25]; [@B29]). Interestingly, these mitotic defects are not seen or much less in their diploidized counterparts, hence haploidy-specific. However, the basis of these haploidy-specific defects remains obscure.

In mitosis, two centrosomes support bipolar spindle formation, which mediates equal segregation of sister chromatids. An abnormal number of centrosomes perturbs proper chromosome segregation, compromising genome integrity in daughter cells. To keep constant centrosome number over cell cycle generations, the progression of centrosome duplication is tightly coupled with that of DNA replication under control of cyclin E-cdk2 ([@B15]; [@B18]; [@B21]; [@B23]; [@B8]). Previously, we found that centrosome duplication was drastically delayed in haploid HAP1 cells compared to their isogenic diploid counterparts, whereas the progression of DNA replication was almost equivalent between these ploidy states ([@B29]). This uncoupling of DNA and centrosome cycles lead to chronic centrosome loss and frequent monopolar spindle formation specifically in haploid cells ([@B29]), potentially affecting haploid stability. However, lack of experimental tools that enable the restoration of normal centrosome number and/or spindle polarity without compromising long-term cell viability has precluded us from directly testing causality of haploidy-associated centrosome loss for haploid instability ([@B29]).

Here, we developed an experimental method to artificially recouple DNA and centrosome cycles by repeating the treatment and removal of thymidine. Using this method, we addressed whether the uncoupling of DNA and centrosome cycles in haploid cells is a primary cause of haploid stability in mammalian somatic cells.

Method {#S2}
======

Cell Culture and Flow Cytometry {#S2.SS1}
-------------------------------

Near haploid human cell line, HAP1 ([@B5]) was purchased from Haplogen. The diploid HAP1 cell line was obtained as previously described ([@B29]). HAP1 cells were cultured in Iscove's Modified Dulbecco's Medium (IMDM; Wako Pure Chemical Industries) supplemented with 10% fetal bovine serum and 1× antibiotic-antimycotic (Sigma-Aldrich). Haploid cells were regularly maintained by size-based cell sorting as previously described ([@B29]). For DNA content analysis or detection of dying cells, cells were stained with 10 μg/ml Hoechst 33342 (Dojindo) or 1 μg/ml propidium iodide (PI, Dojindo), respectively, for 15 min at 37°C, and fluorescence intensity was analyzed using a JSAN desktop cell sorter (Bay Bioscience).

Intermittent Cell Cycle Blockage {#S2.SS2}
--------------------------------

In each inhibitor treatment/release cycle, cells were treated with 500 μM thymidine (Wako), 1 μM PD-0332991 (MedChemExpress), or 1 μM LY-2835219 (Sigma-Aldrich) for 16 h, then rinsed with and incubated in supplemented IMDM without the inhibitors for 8 h. In the case of roscovitine co-treatment with thymidine, 5 μM roscovitine (Sigma-Aldrich) was introduced 5 h after the introduction of thymidine, treated for 11 h, and then washed out along with thymidine. Roscovitine was introduced from the second cycle of the thymidine treatment/release cycles. Cell passage was conducted using 0.05% trypsin-EDTA (Wako) typically once two days while cells were cultured in inhibitors-free medium. For immunofluorescence imaging, cells were fixed and stained 8 h after the release from the third inhibitor treatment. For live imaging, the cell culture medium was exchanged to supplemented phenol red-free IMDM (Thermo Fisher Scientific), and cells were imaged from 2 h after the release from the third inhibitor treatment. For monitoring the dynamics of DNA content in the long-term culture experiments, cells were subjected to flow cytometry 8 h after release from inhibitor treatment at the cycles of inhibitor treatment/release indicated in the main text and the corresponding figure.

Immunofluorescence (IF) Staining {#S2.SS3}
--------------------------------

Cells were fixed with 100% methanol at −20°C for 10 min. Fixed samples were treated with blocking buffer (150 mM NaCl; 10 mM Tris-HCl, pH 7.5; 5% bovine serum albumin; and 0.1% Tween 20) for 30 min at 25°C, and incubated with primary and secondary antibodies overnight each at 4°C. Following each treatment, cells were washed 2--3 times with Dulbecco's phosphate-buffered saline. Rat monoclonal anti-α-tubulin (YOL1/34, EMD Millipore); mouse monoclonal anti-centrin (20H5, EMD Millipore), goat anti-mouse Alexa Fluor 488-conjugated (ab150117, Abcam), and goat anti-rat Alexa Fluor 568-conjugated (ab175710, Abcam) antibodies were used at a dilution of 1:1000.

Microscopy {#S2.SS4}
----------

Fixed cells were observed at 25°C under a TE2000 microscope (Nikon) equipped with a × 100 1.4 numerical aperture (NA) Plan-Apochromatic objective lens (Nikon), a CSU-X1 confocal unit (Yokogawa), and an iXon3 electron multiplier-charge coupled device camera (Andor). Living cells were observed for 24 h at 37°C with 5% CO~2~ under a Ti-2 microscope (Nikon) equipped with a × 40 0.95 NA Plan-Apochromatic objective lens (Nikon), and Zyla4.2 sCMOS camera (Andor). Sir-tubulin (Cytoskeleton, Inc.) was treated at 250 nM for live imaging. Image acquisition was controlled by μManager (Open Imaging).

Colorimetric Cell Proliferation Assay {#S2.SS5}
-------------------------------------

For cell viability assay, 1,350 (haploid) or 675 (diploid) cells were seeded on each well of 96-well plates. After 24 h, cells were treated with different concentrations of thymidine. Forty-four h after the thymidine addition, 5% Cell Counting Kit-8 (Dojindo) was added to the culture, incubated for 4 h, and absorbance at 450 nm was measured using the Sunrise plate reader (Tecan). The absorbances of thymidine treated cells were normalized to those of the corresponding non-treated controls.

Mathematical Modeling and Simulations {#S2.SS6}
-------------------------------------

A mathematical cell population transition model was described previously ([@B29]). In the case of intermittent cell cycle arrest, both haploid and diploid cells were assumed to double once every 24 h. Computer programs were written using MATLAB (MathWorks). Parameters used in simulations are listed in [Supplementary Table S1](#TS1){ref-type="supplementary-material"}.

Results {#S3}
=======

Restoration of Mitotic Control by an Artificial Slowing of G1/S Phase in Haploid HAP1 Cells {#S3.SS1}
-------------------------------------------------------------------------------------------

We reasoned that if the uncoupling of DNA replication and centrosome duplication cycles is a primary cause of mitotic defects and genome instability in haploid HAP1 cells, these haploidy-linked defects would be circumvented by artificial recoupling of DNA and centrosome cycles. Excess thymidine treatment blocks DNA synthesis through competitive inhibition, causing G1/S arrest ([@B4]). In certain transformed cell lines or early embryonic cells, centrosome duplication or over-amplification takes place even when DNA replication is blocked ([@B9]; [@B26]; [@B2]; [@B17]). Previously, we found that blockage of G1/S by thymidine allowed the continuous progression of centriole duplication in HAP1 ([@B29]). Therefore, we first established an experimental method that chronically delays the DNA replication cycle and recouples it to the centrosome duplication cycle by thymidine. To extend G1/S in each round of cell cycle without halting cell proliferation, we intermittently repeated cycles of 16-h thymidine treatment followed by the subsequent 8-h incubation without thymidine ([Figure 1A](#F1){ref-type="fig"}; note that we previously quantified average cell cycle length of haploid HAP1 cells to be 13.4 h) ([@B29]). Using flow cytometry, we confirmed that cell cycle progression was effectively blocked and released by thymidine treatment/removal cycles ([Supplementary Figures S1A--D](#FS1){ref-type="supplementary-material"}). Prolonged treatment of thymidine could potentially affect cell viability through the upregulation of p53 ([@B3]). Therefore, we also monitored cell death events during the first thymidine release by detecting PI incorporation and sub-G1 population in the timecourse flow cytometric analysis ([Supplementary Figures S1D--F](#FS1){ref-type="supplementary-material"}). Although there was a small increase in the sub-G1 population after thymidine washout, no significant difference was observed in PI incorporation between non-treated control and thymidine-released cells ([Supplementary Figure S1F](#FS1){ref-type="supplementary-material"}). Therefore, the thymidine treatment/release cycle did not cause drastic cell death. Thymidine cycles resulted in a significant increase in cell size compared to mock-treated control, while the cells kept the haploid DNA content ([Supplementary Figure S1C](#FS1){ref-type="supplementary-material"}). Next, we tested the effects of thymidine cycles on mitotic spindle organization and mitotic progression in the haploid state by live imaging of HAP1 cells stained with a fluorescent microtubule marker SiR-tubulin ([Figure 1B](#F1){ref-type="fig"}). Most of the diploid control cells formed bipolar spindle by 20 min after nuclear envelope breakdown (NEBD) and entered anaphase by 35 min after NEBD ([Figures 1C,D](#F1){ref-type="fig"}). When compared to diploid cells, monopolar-to-bipolar conversation and anaphase onset were significantly delayed in haploid cells with a substantial proportion of them arrested in the monopolar state for an extremely long time (\>50 min; [Figures 1C,D](#F1){ref-type="fig"}). Out of 387 haploid cells whose mitotic consequences could be specified, 4 or 5 cells underwent mitotic death or mitotic slippage (mitotic exit without cytokinesis), respectively ([Figure 1E](#F1){ref-type="fig"}). In the majority of the cases, these mitotic defects took place after severe mitotic arrest (\>50 min; [Figure 1E](#F1){ref-type="fig"}). In contrast, these mitotic defects were not observed in diploid control ([Figure 1E](#F1){ref-type="fig"}). Interestingly, after three cycles of thymidine treatment/release in haploid cells, the delay in spindle bi-polarization and mitotic progression were significantly mitigated, and the frequency of the extreme delay (\>50 min) in these processes was also reduced ([Figures 1C,D](#F1){ref-type="fig"}). Thymidine cycles also suppressed mitotic slippage ([Figure 1E](#F1){ref-type="fig"}). To investigate the effects of thymidine cycles on mitotic centrosome number, we also conducted immunostaining of centrin-2 (centriole marker) and α-tubulin (spindle marker) in non-treated or thymidine cycles-treated haploid cells ([Figures 2A--D](#F2){ref-type="fig"}). Whereas non-treated haploid cells showed frequent centriole loss accompanied by spindle monopolarization, both normal mitotic centriole number and spindle bipolarity were significantly restored after three cycles of thymidine treatment/release ([Figures 2C,D](#F2){ref-type="fig"}). Therefore, artificial slowing of G1/S recoupled DNA and centrosome cycles, largely improving mitotic control in haploid cells.

![Restoration of mitotic progression by intermittent extension of G1/S phase in haploid HAP1 cells. **(A)** Experimental scheme of thymidine treatment/release cycles. **(B)** Live images of SiR-tubulin-stained HAP1. Images were taken at 5-min intervals. NEBD was set as 0 min. Broken lines: cell boundaries. Arrow: a dead cell. **(C,D)** Distribution of time duration for monopolar-to-bipolar conversion **(C)** or NEBD-to-anaphase transition **(D)**. At least 393 cells from two independent experiments were analyzed. NEBD or anaphase onset was defined as the time when the nuclear structure devoid of SiR-tubulin disappeared or when the spindle structure initiated the anaphase elongation, respectively. Insets: Means ± standard error (SE). Asterisks indicate a statistically significant difference from non-treated haploid control (^∗^*p* \< 0.01, two-tailed *t*-test). Cells that showed extreme delay (\>50 min) were excluded from the mean calculation as outliers. **(E)** The frequency of mitotic defects. At least 387 cells pooled from two independent experiments were analyzed. **(F)** Theoretical model simulation of haploid instability in long-term culture with or without intermittent cell cycle arrest and/or mitotic restoration.](fcell-08-00721-g001){#F1}

![Restoration of normal mitotic centrosome number and spindle bipolarity by intermittent extension of G1/S phase in haploid HAP1 cells. **(A)** Experimental scheme of inhibitors treatment/release cycles. **(B)** Immunostaining of α-tubulin and centrin in haploid cells after three cycles of inhibitors treatment/release. Insets show 3× enlarged images of the centrioles. **(C,D)** Frequency of spindle polarities **(C)** or centriole numbers **(D)** in mitotic cells. Means ± SE of three independent experiments (\**p* \< 0.05, \*\**p* \< 0.01, two-tailed *t*-test). At least 154 cells were analyzed per condition.](fcell-08-00721-g002){#F2}

Improvement of Haploid Stability in Long-Term Culture by the Recoupling of DNA and Centrosome Cycles {#S3.SS2}
----------------------------------------------------------------------------------------------------

We next theoretically estimated impacts of the thymidine-mediated improvement of mitotic control on haploid stability using a mathematical cell population model developed in our previous study ([@B29]) (see section "Method"). The model simply assumes that haploid and diploid cells proliferate exponentially with their characteristic doubling times, while haploid cells undergo mitotic death or diploidize through mitotic slippage at the frequencies quantified in the live imaging ([Figure 1E](#F1){ref-type="fig"}). We previously found that diploid HAP1 cells proliferate faster than haploid cells with a cell cycle length of 11.9 h (vs. 13.4 h in haploid), which promotes the expansion of diploidized cells over haploid ([@B29]). To test the potential influence of intermittent cell cycle arrest on the haploid-to-diploid conversion, we first compared a theoretical condition in which haploid and diploid cells proliferate with their observed doubling times with another condition in which both of them double only once every 24 h ([Figure 1F](#F1){ref-type="fig"}). Even when we assumed the identical frequencies of mitotic death and mitotic slippage in these two conditions, the haploid-to-diploid conversion was much slowed down by intermittent cell cycle arrest ([Figure 1F](#F1){ref-type="fig"} and [Supplementary Table S1](#TS1){ref-type="supplementary-material"}). Therefore, the reduction of mitotic frequency and the cancelation of the ploidy-dependent growth difference by the intermittent cell cycle arrest alone make a substantial contribution to haploid stability. Then, we compared the haploid-to-diploid conversion between theoretical conditions in which mitotic death and mitotic slippage occurred at different frequencies as observed between thymidine cycles-treated and non-treated haploid cells. The simulation showed that the observed level of mitotic restoration by thymidine cycles could substantially improve haploid stability even if we removed from consideration the effect of intermittent cell cycle arrest (compare broken black and red lines in [Figure 1F](#F1){ref-type="fig"}). Therefore, the modulation of mitotic control through the recoupling of DNA and centrosome cycles was predicted to profoundly improve the long-term stability of the haploid state.

Next, we experimentally tested the model prediction. To evaluate the net contribution of mitotic restoration to haploid stability independently from that of intermittent cell cycle arrest, we needed to set control conditions in which cell cycle was intermittently arrested while DNA and centrosome cycles remained uncoupled. For this, (i) a cdk2 inhibitor roscovitine was co-treated in thymidine cycles to inhibit cdk2-mediated centriole duplication in G1/S ([@B15]; [@B18]; [@B21]; [@B23]), or (ii) early G1 phase was intermittently blocked instead of G1/S by cdk4/6 inhibitor (PD-0332991 or LY-2835219) treatment/release cycles ([@B7]; [@B10]) ([Figure 2A](#F2){ref-type="fig"}). In the case of thymidine and roscovitine co-treatment, we had to avoid blockage of mitotic progression by roscovitine-mediated cdk1 inhibition. For this, roscovitine was introduced at 13 h after the previous release from thymidine arrest, which was sufficient for the majority of cells to pass through the mitotic phase and to be arrested at the next G1/S boundary ([Supplementary Figures S1A,B](#FS1){ref-type="supplementary-material"}). Cell cycle profile and cell size distribution were almost identical between cells in the thymidine cycles and those in thymidine and roscovitine cycles ([Supplementary Figures S1B,C](#FS1){ref-type="supplementary-material"}). However, roscovitine substantially attenuated the restoration of mitotic centriole number and spindle bipolarity in thymidine cycles-treated haploid cells ([Figures 2B--D](#F2){ref-type="fig"}). Similarly, though PD-0332991 or LY-2835219 cycles effectively blocked and released cell cycle progression ([Supplementary Figure S1B](#FS1){ref-type="supplementary-material"}), restoration of mitotic centrosome number and spindle bipolarity in the cells treated with these inhibitors was scarce or ignorable ([Figures 2B--D](#F2){ref-type="fig"}). Therefore, restoration of the coupling between DNA replication and centrosome duplication was specifically achieved by the G1/S phase extension in a cdk2-dependent manner. These results demonstrate that the above experimental conditions serve as controls that intermittently block cell cycle progression while keeping DNA and centrosome cycles uncoupled in haploid cells.

We next conducted long-term continuous passages while intermittently blocking early G1 or G1/S by cdk4/6 inhibitors or thymidine, respectively, on the same schedule of the cycle as described in [Figure 2A](#F2){ref-type="fig"}. After continuous passages for 30 d, non-treated control haploid cells drastically diploidized, which was marked by a substantial reduction in haploid G1 population (indicated as "1C" peak in flow cytometry in [Figure 3A](#F3){ref-type="fig"}) along with the emergence of diploid G2/M population ("4C" peak); the proportion of haploid G1 reduced to 5.9% on day 30 ([Figure 3B](#F3){ref-type="fig"}). Thymidine cycles drastically suppressed diploidization with the proportion of haploid G1 remaining to be 37% on day 30 ([Figures 3A,B](#F3){ref-type="fig"}). The suppression of diploidization was much milder or ignorable in cdk4/6 inhibitors-treated cells, excluding the possibility that haploid stability was improved merely because of delayed cell proliferation in thymidine cycles. Moreover, co-treatment of roscovitine substantially attenuated the thymidine-mediated haploid stabilization with the proportion of haploid G1 being 27% on day 30. These data support the idea that the uncoupling of DNA and centrosome cycles is a primary cause of haploid instability in HAP1. During the prolonged culture over 30 days with thymidine cycles, cells became insensitive to thymidine-mediated cell cycle arrest ([Figure 3C](#F3){ref-type="fig"}) ([@B24]), which precluded further preservation of the haploid cell population.

![Improvement of haploidy stability in G1/S phase-extended cells in long-term passages. **(A)** Flow cytometric analysis of DNA content in Hoechst-stained cells in the long-term passages with or without inhibitors treatment/release cycles. Representative data from two independent experiments. **(B)** Time course of haploid G1 frequency in panel **(A)**. Means of two independent experiments. **(C)** Colorimetric cell proliferation assay of HAP1 cells treated with different concentrations of thymidine before or after long-term thymidine treatment/release cycles. A representative result from two independent experiments is shown (means of duplicates).](fcell-08-00721-g003){#F3}

Discussion {#S4}
==========

In this study, by chronically delaying G1/S progression by the intermittent thymidine treatment, we could establish, for the first time, an experimental condition in which mitotic centrosome number and mitotic control were substantially restored in human haploid somatic cells. Mitotic restoration drastically improved haploid stability. On the other hand, suppression of centrosome restoration by cdk2 inhibition attenuated the effect of G1/S extension on haploid stability. Our results indicate the causality between the haploidy-linked centrosome loss and the instability of the haploid state in human somatic cells.

Because of the rich potential of mammalian haploid cells in bioengineering, many attempts have been made to improve haploid stability. Different studies have reported that diploidization in mouse haploid ES cells is substantially suppressed by optimized inhibition of wee1 kinase, cdk1, Rho-kinase or GSK-3/TGF-β pathways/BMP4 pathway ([@B27]; [@B14]; [@B20]), or by gene manipulations including ectopic expression of aurora B kinase or Dnmt3b ([@B11]; [@B13]). Intriguingly, the effects of these treatments on haploid stability have been attributed to the acceleration of G2/M. Our results are consistent with this proposal in that we also observed a correlation between the restoration of normal mitotic progression and haploid stability. It was not determined how the acceleration of G2/M improved haploid stability in the previous studies. However, since our results suggest that the haploidy-specific mitotic slippage makes an important contribution to haploid instability, a possible explanation would be that G2/M acceleration stabilizes the haploid state by reducing the chance of mitotic slippage. Another possible mechanism of the G2/M acceleration-mediated haploid stabilization may be through the modulation of p53 state in haploid cells. A previous study reported haploidy-linked p53 upregulation, which limits the proliferation of haploid cells ([@B25]). Interestingly, recent studies have shown that prolonged mitosis arising from centrosome loss is sufficient to cause p53-dependent cell growth arrest ([@B6]; [@B19]; [@B22]). Therefore, we attempted to address whether centrosome restoration by thymidine cycles could suppress p53 upregulation in haploid cells. However, thymidine treatment itself triggered p53 upregulation presumably because of the replication folk stress (not shown) ([@B3]), precluding us from testing this idea. The thymidine-driven p53 upregulation may put a selective pressure that excludes a fraction of the haploid cells prone to p53-dependent cell death in early thymidine cycles, potentially contributing to slowing of haploid-to-diploid conversion. However, the absence of drastic cell death events upon the thymidine treatment/release cycle indicates that the influence of this possible effect of thymidine was minimum or limited in our experimental system ([Supplementary Figure S1F](#FS1){ref-type="supplementary-material"}).

Our study demonstrated the feasibility of haploid stabilization by the recoupling of DNA and centrosome cycles. However, to improve the versatility in routine cell maintenance, simpler methods for chronic recoupling of DNA and centrosome cycles are desirable. One possible approach would be to establish haploid mutant cell lines in which DNA replication or centrosome duplication is chronically delayed or accelerated, respectively, while cell viability remains unaffected. The loss-of-function of non-essential activators of DNA replication or promotion of centrosome duplication factors would be potential gene manipulation approaches. Our study provides a basis for an understanding of the mechanism that determines ploidy dynamics in mammalian somatic cells, as well as for further improvements of haploid cell technologies.

Data Availability Statement {#S5}
===========================

All datasets presented in this study are included in the article/[Supplementary Material](#DS1){ref-type="supplementary-material"}.

Author Contributions {#S6}
====================

RU: conceptualization, resources, and writing -- original draft. KYo, KYa, and RU: methodology, investigation, formal analysis, and writing -- review and editing. KYa and RU: funding acquisition. All authors contributed to the article and approved the submitted version.

Conflict of Interest {#conf1}
====================

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

**Funding.** This work was supported by Grant-in-Aid for JSPS Fellows to KYa (19J12210), Grants-in-Aid for Scientific Research B (19H03219), on Innovative Areas "Singularity Biology (No. 8007)" (19H05413), Fostering Joint International Research B (19KK0181), and JSPS Bilateral Joint Research Project (JPJSBP120193801) of MEXT, the Princess Takamatsu Cancer Research Fund, the Kato Memorial Bioscience Foundation, the Orange Foundation, the Smoking Research Foundation, the Suhara Memorial Foundation, and the Nakatani Foundation to RU.

We thank Kimino Sato and Takahiro Yamamoto for technical assistance, and the Global Facility Center at Hokkaido University for the flow cytometer. This manuscript has been released as a pre-print at [bioRxiv](https://www.biorxiv.org/) ([@B31]).

Supplementary Material {#S9}
======================

The Supplementary Material for this article can be found online at: <https://www.frontiersin.org/articles/10.3389/fcell.2020.00721/full#supplementary-material>

###### 

Intermittent extension of DNA replication cycle by cell cycle inhibitor treatment/release. **(A)** Experimental scheme of inhibitor treatment/release cycles. **(B,C)** Flow cytometric analysis of DNA content in Hoechst-stained haploid cells in inhibitors treatment/release cycles. Histograms of Hoechst signal and dot plots of forward scatter signal (for the judgment of relative cell size) against the Hoechst signal are shown in panels **(B,C)**, respectively. Representative data from three independent experiments. Note that co-treatment of roscovitine did not change the profile of cell cycle arrest/release in the thymidine treatment/release cycle. **(D,E)** Timecourse flow cytometric analysis of DNA content (Hoechst signal; **D,E**) and PI incorporation **(E)** in haploid cells after the first washout of thymidine. **(F)** Proportions of PI-positive cells or sub-G1 population in panel **(E)**. Means ± SE of three independent experiments (^∗^*p* \< 0.05, two-tailed *t*-test).
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